Table 1. Serum hormone concentrations of patients and controls.
| Groups | TSH (mUI ml−1) | FSH (mUI ml−1) | LH (mUI ml−1) | Testosterone (ng ml−1) | 17β-estradiol (pg ml−1) | Prolactin (ng ml−1) | AbTg (UI ml−1) | AbTPO (UI ml−1) |
|---|---|---|---|---|---|---|---|---|
| A: Patients with DM (HbA1c <7%) | 1.4±2.0 | 4.2±5.0 | 3.2±3.0 | 5.6±3.0 | 13.0±10.0 | 6.0±4.0 | 33.0±20.0 | 12.0±8.0 |
| B: Patients with DM (HbA1c 7%-10%) | 1.8±3.0 | 4.8±4.0 | 3.6±2.0 | 5.3±4.0 | 18.0± 7.0 | 8.0±6.0 | 44.0±18.0 | 18.0±8.0 |
| C: Patients with DM (HbA1c >10%) | 1.2±2.0 | 3.9±3.0 | 2.9±4.0 | 5.4±3.0 | 11.0±10.0 | 4.0±5.0 | 23.0±10.0 | 15.0±4.0 |
| OAT control group | 1.9±3.5 | 4.0±2.0 | 3.0±3.0 | 5.8±6.0 | 12.0±6.0 | 6.0±3.0 | 44.0±12.0 | 18.0±6.0 |
| Fertile control group | 1.5±3.0 | 4.3±6.0 | 2.6±2.0 | 5.4±5.0 | 14.0±5.0 | 9.0±2.0 | 33.0±10.0 | 15.0±6.0 |
Abbreviations: AbTg, thyreoglobulin antibodies; AbTPO, thyreoperoxidase antibodies; DM, diabetes mellitus; FSH, follicle-stimulating hormone; HbA1c, glycosylated haemoglobin; LH, luteinzing hormone; OAT, oligoasthenoteratozoospermia; TSH, thyroid-stimulating hormone.